May 14, 2012 — Lantheus Medical Imaging Inc. announced new manufacturing and supply agreements with Jubilant HollisterStier LLC (JHS). Under separate agreements, JHS will manufacture Cardiolite (kit for the preparation of technetium Tc99m sestamibi for injection) products and Neurolite (kit for the preparation of technetium Tc99m bicisate for injection), each for an initial term of five years and each with an option to renew for an additional five years thereafter.

May 14, 2012 — GE Healthcare introduced a new version of its Vscan pocket-sized visualization tool, developed to deliver imaging capabilities at the point of care. Based on feedback from current Vscan users, the new version features extended battery life, a more intuitive user interface and enhanced reporting capabilities.

May 14, 2012 — During the Heart Rhythm Society (HRS) 2012 scientific sessions last week, Biosense Webster Inc. announced it created strategic collaboration agreements with GE Healthcare and Siemens Healthcare. The agreements will make it easier for the vendors to work jointly to create advanced electrophysiology (EP) labs

May 14, 2012 — Stereotaxis Inc. released to the European market the V-Sono intra-cardiac echocardiography (ICE) manipulator module for the Vdrive Remote Navigation System.

May 14, 2012 – Endosense said there has been strong interest and significant advancement in the move toward making contact-force sensing a standard-of-care in catheter ablation procedures. Participating at the Heart Rhythm (HRS) 2012 meeting last week in Boston, the company noted a wealth of new clinical abstracts and a new HRS/EHRA/ECAS consensus statement as key validation points supporting the value of the sensory parameter in cardiac ablation.

May 14, 2012 ? Boston Scientific Corp. announced extended warranties of up to 10 years, depending on the model, for its Energen and Incepta implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The company said the new warranty program is the longest available in the industry and provides physicians, patients and payers across Europe warranties up to five years longer than other currently-marketed cardiac devices. Following are the devices and their warranties. 

Sorin Group announced at the Heart Rhythm Society (HRS) annual scientific sessions, the publication of the CLEAR study results in Europace (May 1, 2012, doi:10.1093/europace/eus059). The study demonstrates the clinical benefit of the SonR sensor based cardiac resynchronization therapy (CRT) optimization system in heart failure (HF) patients.

May 14, 2012 -- Two types of stent systems are both effective in treating patients who have severe forms of peripheral artery disease (PAD), according to results of the MOBILITY trial presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now